These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6534380)

  • 1. Interaction between phenprocoumon and phytomenadion: a pharmacokinetic investigation in healthy volunteers.
    Haustein KO
    Biomed Biochim Acta; 1984; 43(12):1417-24. PubMed ID: 6534380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic properties of oral anticoagulants, especially phenprocoumon.
    Haustein KO
    Semin Thromb Hemost; 1999; 25(1):5-11. PubMed ID: 10327214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Individualization of drug dosage during long-term treatment with phenprocoumon (Falithrom).
    Haustein KO; Richter M; Vogel G; Mittag E
    Int J Clin Pharmacol Biopharm; 1978 Aug; 16(8):372-6. PubMed ID: 689796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of phenprocoumon.
    Haustein KO; Hüller G
    Int J Clin Pharmacol Ther; 1994 Apr; 32(4):192-7. PubMed ID: 8032579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Observations in phenprocoumon (Marcumar) poisoning. Elimination and serum binding of the anticoagulant atatoxic blood concentration].
    Held H; von Busse G; Meissner J
    Dtsch Med Wochenschr; 1980 Jun; 105(24):860-3. PubMed ID: 7418621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of liver cirrhosis on the pharmacokinetics of phenprocoumon.
    Kitteringham NR; Büstgens L; Brundert E; Mineshita S; Ohnhaus EE
    Eur J Clin Pharmacol; 1984; 26(1):65-70. PubMed ID: 6714293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of wheat bran on the pharmacokinetics of phenprocoumon in normal volunteers.
    Kitteringham NR; Mineshita S; Ohnhaus EE
    Klin Wochenschr; 1985 Jun; 63(12):537-9. PubMed ID: 2993733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pharmacokinetic model of the adjustment of phenprocoumon (Falithrom) dosage.
    Barthel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):838-50. PubMed ID: 6083961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Probenecid affects liver metabolism].
    Bammel A; Mönig H; Zurborn KH; Ohnhaus EE; Kirch W
    Schweiz Med Wochenschr; 1989 Dec; 119(50):1831-4. PubMed ID: 2609138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjustment of phenprocoumon dosage utilizing a pharmacokinetic model.
    Böhm K; Vogel G; Barthel W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):141-6. PubMed ID: 2459009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of flupirtine coadministration on phenprocoumon plasma concentrations and prothrombin time.
    Harder S; Thürmann P; Hermann R; Weller S; Mayer M
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):577-81. PubMed ID: 7874369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phenylbutazone and sulfinpyrazone interaction with oral anticoagulant phenprocoumon.
    O'Reilly RA
    Arch Intern Med; 1982 Sep; 142(9):1634-7. PubMed ID: 7114982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of induction and inhibition of drug metabolism on pharmacokinetics and anticoagulant activity of the enantiomers of phenprocoumon in rats.
    Schmidt W; Trenk D; Jähnchen E
    Pharmacology; 1980; 21(5):313-22. PubMed ID: 7433511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study on interactions between pirprofen and phenprocoumon].
    Marbet GA; Duckert F; Schönenberger PM
    Fortschr Med; 1985 Feb; 103(SPEC NO 7A):207-9. PubMed ID: 3872834
    [No Abstract]   [Full Text] [Related]  

  • 15. [Studies of the interractions of cyclamate with phenprocomon (author's transl)].
    Kinawi A; Baumgartl I
    J Clin Chem Clin Biochem; 1977 Jun; 15(6):345-8. PubMed ID: 894206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of (+)-Catechin and Dithiocarb on the Pharmacokinetics of Phenprocoumon, Tolbutamide and Three Inhalation Anesthetics in rats].
    Siegers CP; Iven H
    Arzneimittelforschung; 1982; 32(11):1437-40. PubMed ID: 6295415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lysine clonixinate on the pharmacokinetics and anticoagulant activity of phenprocoumon.
    Russmann S; Dilger K; Trenk D; Nagyivanyi P; Jähnchen E
    Arzneimittelforschung; 2001 Nov; 51(11):891-5. PubMed ID: 11765590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of incadronate, a new bisphosphonate, in healthy volunteers and patients with malignancy-associated hypercalcemia.
    Usui T; Oiso Y; Tomita A; Ogata E; Uchida T; Ikeda K; Watanabe T; Higuchi S
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):239-44. PubMed ID: 9208339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholestyramine interrupts the enterohepatic circulation of phenprocoumon: a new therapeutic possibility in the treatment of phenprocoumon overdose].
    Meinertz T; Jähnchen E; Gilfrich HJ; Groth U; Jonen HG
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1582-4. PubMed ID: 347787
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of sulfinpyrazone on the disposition of pseudoracemic phenprocoumon in humans.
    Heimark LD; Toon S; Gibaldi M; Trager WF; O'Reilly RA; Goulart DA
    Clin Pharmacol Ther; 1987 Sep; 42(3):312-9. PubMed ID: 3621786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.